Kinetic solubility and lipophilicity evaluation connecting formulation technology strategy perspective

Journal of Drug Delivery Science and Technology

Volumn 33, Issue , 2016, Pages 13-18

  Yamamoto, Katsuhiko ^a   Ikeda, Yukihiro ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Crystal; Formulation strategy; Lipophilicity; Solubility; Solubilization

Indexed keywords

ALBENDAZOLE; CORTICOSTERONE; DICLOFENAC; GLYCOCHENODEOXYCHOLIC ACID; GRISEOFULVIN; HYDROCHLOROTHIAZIDE; INDOMETACIN; LANSOPRAZOLE; TAMOXIFEN;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG FORMULATION; DRUG SOLUBILITY; ENTERIC COATED TABLET; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPOPHILICITY; PARTICLE SIZE; PHYSICAL CHEMISTRY; RETENTION TIME; SOLUBILIZATION; TEMPERATURE; TIME; ULTRAVIOLET RADIATION;

EID: 84960415742     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2016.03.002     Document Type: Article

References (25)

1. L. Ping, and L. Zhao Developing early formulations: practice and perspective Int. J. Pharm. 341 2007 1 19
2. K. Kawakami Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs Adv. Drug Deliv. Rev. 64 2012 480 495
3. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug. Deliv. Rev. 23 1997 3 25
4. L. Di, P.V. Fish, and T. Mano Bridging solubility between drug discovery and development Drug Discov. Today 17 2012 486 495
5. J. Brouwers, M.E. Brewrter, and P. Augustijns Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J. Pharm. Sci. 98 2009 2549 2572
6. J. Alsenz, and M. Kansy High throughput solubility measurement in drug discovery and development Adv. Drug. Deliv. Rev. 59 2007 546 567
7. A. Glomme, J. März, and J.B. Dressman Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities J. Pharm. Sci. 94 2005 1 16
8. K. Sugano, T. Kato, K. Suzuki, K. Keiko, T. Sujaku, and T. Mano J. Pharm. Sci. 95 2006 2115 2122
9. D. Eldera, and R. Holm Aqueous solubility: simple predictive methods (in silico, in vitro and bio-relevantapproaches) Int. J. Pharm. 453 2013 3 11
10. C. Zhu, L. Jiang, T. Chen, and K. Hwang A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential Eur. J. Med. Chem. 37 2002 399 407
11. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug. Deliv. Rev. 23 1997 3 25
12. Y. Kawabata, K. Wada, M. Nakatani, and S.Y.S. Onoue Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications Int. J. Pharm. 420 2011 1 10
13. K. Valko Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution J. Chromatogr. A 1037 2004 299 310
14. Y. Henchoz, B. Bard, D. Guillarme, P. Carrupt, J. Veuthey, and S. Martel Analytical tools for the physicochemical profiling of drug candidates to predict absorption/distribution Anal. Bioanal. Chem. 394 2009 707 729
15. K. Masumoto, A. Takeyasu, K. Oizumi, and T. Kobayashi Yakugaku Zasshi 115 1995 213 220
16. Chemical Substances Control Law from the Ministry of Economy, Trade and Industry Japan (http://www.safe.nite.go.jp/kasinn/genkou/kasinhou02test3.html).
17. K.A. Chu, and S.H. Yalkowsky An interesting relationship between drug absorption and melting point Int. J. Pharm. 373 2009 24 40
18. P. Sanphui, D.V. Kusum, D. Clara, N. Malviya, S. Ganguly, and G.R. Desiraju Mol. Pharm. 12 2015 1615 1622
19. L.V. Chau, C. Park, and L.B. Lee Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs Eur. J. Pharm. Biopharm. 85 2013 799 813
20. K. Sugano, A. Okazaki, S. Sugimoto, S. Tavornvipas, A. Omura, and T. Mano Solubility and dissolution profile assessment in drug discovery, drug metab Pharmacokinet 22 2007 225 254
21. Abu T.M. Serajuddin Salt formation to improve drug solubility Adv. Drug Deliv. Rev. 59 2007 603 616
22. Mei-Ling Chen, Gordon L. Amidon, Leslie Z. Benet, Hans Lennernas, and Lawrence X. Yu The BCS, BDDCS, and regulatory guidances Pharm. Res. 28 2011 1774 1778
23. V. Jannina, S. Chevriera, M. Michenauda, C. Dumonta, S. Belottia, Y. Chavanta, and F. Demarne Development of self-emulsifying lipid formulations of BCS class II drugs with low to medium lipophilicity Int. J. Pharm. 495 2015 385 392
24. J. Rautio, H. Kumpulainen, T. Heimbach, R. Oliyai, D. Oh, T. Järvinen, and J. Savolainen Prodrugs: design and clinical applications Nat. Rev. Drug Discov. 7 2008 255 270
25. S.I. Ms, N.C. Derle, and R. Bhamber Permeability enhancement techniques for poorly permeable drugs: a review J. Appl. Pharm. Sci. 2 2012 34 39